Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Lactobacillus Dual Probiotic Capsules for Bacterial Vaginosis
NCT07418957Phase 3Completed
- Sponsor
- Longchuangji Pharmaceutical
- Start
- Jun 2024
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bacterial vaginosis (BV) (2 arms), sponsored by Longchuangji Pharmaceutical. Primary endpoint: Clinical Cure Rate. Started Jun 2024; status: completed.
02
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT07418957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07418957.